Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details)

v3.22.1
SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS - 2021 Equity Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
2 Months Ended 10 Months Ended 12 Months Ended
Dec. 09, 2021
Dec. 07, 2021
Nov. 09, 2021
Dec. 31, 2021
Nov. 08, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares authorized and reserved for future issuance (in shares)     31,900,000          
Granted (in shares)       8,763,754   8,763,754    
Lower exercise price (in usd per share)     $ 10.00          
Upper exercise price (in usd per share)     $ 14.00          
Period to comply with minimum personal investment requirement           5 years    
Noncash stock compensation expense       $ 4,821 $ 156   $ 0 $ 0
Unrecognized compensation expense       50,200   $ 50,200    
Compensation expense recognized       4,821 $ 156   $ 0 $ 0
Chief Executive Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Minimum personal investment requirement       2,200   2,200    
Chief Financial Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Minimum personal investment requirement       1,900   1,900    
Director                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Minimum personal investment requirement       $ 1,500   1,500    
Stock Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expiration period 10 years              
Noncash stock compensation expense           $ 3,600    
Period for recognition           2 years    
Bridge Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (in shares)           245,004    
Target EBITDA     $ 136,000          
5-Year Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (in shares)           8,518,750    
Award vesting period     5 years          
5-Year Option | Tranche One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Minimum compounded annual growth     13.50%          
Percent vested     25.00%          
5-Year Option | Tranche Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Minimum compounded annual growth     23.50%          
Percent vested     100.00%          
Common Stock | Consultant                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted in period (in shares)   100,000            
Grant date fair value (in usd per share)   $ 11.75            
Compensation expense recognized           $ 1,200